Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,298 | 37,841 | 85,388 | 43,994 | 57,206 |
| Marketable Securities | 156,566 | 210,953 | 284,522 | 205,238 | 186,796 |
| Receivables | 6,882 | 38,645 | 39,618 | 49,036 | 60,831 |
| TOTAL | $204,336 | $299,852 | $422,791 | $311,713 | $319,021 |
| Non-Current Assets | |||||
| PPE Net | 35,395 | 32,688 | 11,919 | 6,173 | 5,943 |
| Investments And Advances | 0 | 0 | 0 | 29,285 | 108,416 |
| Other Non-Current Assets | 41,001 | 44,112 | 27,565 | 28,239 | 5,411 |
| TOTAL | $76,396 | $76,800 | $39,484 | $63,697 | $119,770 |
| Total Assets | $280,732 | $376,652 | $462,275 | $375,410 | $438,791 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,948 | 8,002 | 4,097 | 6,000 | 9,540 |
| Accrued Expenses | 12,751 | 13,547 | 18,339 | 20,936 | 22,429 |
| Other current liabilities | 30,710 | 34,462 | 35,076 | N/A | N/A |
| TOTAL | $48,555 | $57,535 | $62,787 | $29,827 | $36,172 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 167,460 | 190,303 | 182,753 | 24,249 | 3,190 |
| TOTAL | $167,460 | $190,303 | $182,753 | $24,249 | $3,190 |
| Total Liabilities | $216,015 | $247,838 | $245,540 | $54,076 | $39,362 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,863 | 21,194 | 21,059 | 20,797 | 20,325 |
| Common Shares | 214 | 212 | 211 | 208 | 202 |
| Retained earnings | -404,929 | -323,040 | -206,995 | -73,179 | 48,576 |
| Other shareholders' equity | -339 | 302 | -1,174 | -3,724 | -382 |
| TOTAL | $64,717 | $128,814 | $216,735 | $321,334 | $399,429 |
| Total Liabilities And Equity | $280,732 | $376,652 | $462,275 | $375,410 | $438,791 |